• SENSEX 80,998.25
    260.74 (+0.32%)
  • BANKNIFTY 55,676.85
    76.90 (+0.14%)
  • Alkem Lab
    4,855.10 4,409.90(%)
  • Tata Technolog.
    748.30 595.05(%)
  • Aditya Bir. Fas.
    76.10 76.10(%)
  • Kaynes Tech
    5,550.00 2,811.20(%)
  • Indegene
    585.90 468.90(%)
  • Cochin Shipyard
    2,175.00 2,977.10(%)
  • Reliance Power
    62.12 62.80(%)
  • Ircon Intl.
    223.60 351.65(%)
  • Garden Reach Sh.
    3,464.85 3,464.85(%)
  • Suzlon Energy
    66.55 45.13(%)
  • Swiggy
    365.00 617.00(%)
  • Mazagon Dock
    3,406.00 1,200.00(%)
  • Rail Vikas
    434.70 647.00(%)
  • Choice Intl.
    707.75 718.00(%)
  • Eternal Ltd
    247.90 304.50(%)
  • Railtel Corpn.
    449.20 618.00(%)
  • Swan Energy
    463.80 809.70(%)
  • Sika Interplant
    1,125.30 1,125.30(%)
  • Reliance Infra.
    385.90 385.90(%)
  • Vodafone Idea
    6.94 19.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cohance Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74679.0
  • ISIN : INE03QK01018
1,021.80 8 (0.75%)
  • As on 04 Jun 2025 (EOD)

  • Today’s Low

    1,001.10

  • Today’s High

    1,031.90

  • Open

    1,014.00

  • Perv Close

    1,014.20

  • 52W Low

    600.05

  • 52W High

    1,360.00

Key Indicators

  • P/E(TTM)

    95.63

  • Mar.Cap (₹Cr.)

    26,011.45

  • Div & Yield %

    0.00

  • Book Value(₹)

    90.96

  • Debt-Equity Ratio

    0.75

  • AGM Date

    04-Jun-2025

  • EPS

    10.67

  • P/E Ratio

    95.63

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    26,011.45

  • RONW (%)

    14.11

  • ROCE (%)

    18.69

Score Board

  • Equity (₹ in Cr.)

    25.46

  • BV (₹)

    91.00

  • Sales( ₹ in Cr.)

    1,093.51

  • NP (in Cr.)

    271.71

  • NP Var(%)

    0.0

  • Div%

    0.0

  • CPS (₹)

    12.90

  • EPS (₹)

    10.70

  • Traded Value (₹ in Lakhs)

    25,975.81

  • 52 Week High

    1,360.00

  • 52 Week Low

    600.05

  • Price BSE

    1020.0

  • Price NSE

    1,022.00

  • Market Capital( in Cr.)

    25,975.81

  • P/C Ratio

    78.90

  • P/E Ratio

    95.60

  • Price Vs.BV

    10.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,024.99 1,330.08 1,320.22 1,009.72 833.79 377.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,024.99 1,330.08 1,320.22 1,009.72 833.79 377.83
Other Income 55.09 44.55 187.79 14.24 18.12 0.60
Stock Adjustments -53.88 20.94 60.35 8.37 11.05 21.32
Total Income 1,026.20 1,395.57 1,568.36 1,032.33 862.96 399.75
EXPENDITURE :            
Raw Materials 248.38 421.36 459.46 310.32 240.24 124.52
Power and Fuel Cost 46.16 71.35 59.55 44.20 38.24 18.06
Employee Cost 126.88 108.58 100.48 76.23 65.10 29.63
Other Manufacturing Expenses 83.19 101.96 115.25 90.76 66.49 33.83
Selling and Administration Expenses 38.85 43.57 52.38 44.93 44.72 16.23
Miscellaneous Expenses 17.75 13.50 11.17 8.61 5.26 5.34
Employee Benefit Expenses 126.88 108.58 100.48 76.23 65.10 29.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 561.21 760.33 798.29 575.05 460.05 227.60
Operating Profit 465.00 635.24 770.08 457.28 402.91 172.15
Interest 7.43 12.75 8.53 11.66 21.81 2.79
Gross Profit 457.57 622.49 761.55 445.62 381.10 169.36
Depreciation 48.79 43.10 39.10 31.64 23.51 11.50
Profit Before Tax 408.78 579.39 722.45 413.98 357.59 157.86
Current Tax 97.37 142.45 157.63 101.72 88.81 33.17
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.59 4.34 6.72 3.62 -1.30 15.42
Reported Net Profit 304.82 432.60 558.10 308.65 270.08 109.27
Extraordinary Items 32.53 10.55 14.53 2.51 4.73 0.11
Adjusted Net Profit 272.29 422.05 543.57 306.14 265.35 109.16
Adjustment below Net Profit -0.30 -0.26 -0.76 -0.84 -13.90 315.80
P & L Balance brought forward 1,490.07 1,276.39 835.88 568.52 390.98 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 218.65 116.83 40.46 78.64 34.09
P & L Balance carried down 1,794.59 1,490.07 1,276.39 835.88 568.52 390.98
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 600.00 500.00 200.00 500.00 0.00
Dividend Per Share(Rs) 0.00 6.00 5.00 2.00 5.00 0.00
Earnings Per Share-Unit Curr 11.97 16.99 21.92 12.12 21.22 20.60
Earnings Per Share(Adj)-Unit Curr 11.97 16.99 21.92 12.12 10.61 -
Book Value 80.76 68.72 59.74 41.84 61.50 0.00
Book Value(Adj)-Unit Curr 80.76 68.72 59.74 41.84 30.75 -

Shareholding Pattern

  • Promoter Group

    66.41%

  • Public Share Holding

    33.59%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 254,078,170 66.41 254,078,170 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 254,078,170 66.41 254,078,170 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 35,009 0.01 35,009 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 211 0.00 211 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 28,233,745 7.38 28,233,745 167
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 8,308,774 2.17 8,308,774 13
Mutual Funds / UTI 33,073,242 8.65 33,037,242 28
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 763,835 0.20 763,835 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 70,414,816 18.41 70,378,816 224
2] Non Institution
Bodies Corporate 28,329,943 7.41 28,325,943 789
Clearing Members 2,141 0.00 2,141 5
Directors of their Relatives 713,259 0.19 713,259 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,460,982 0.64 2,460,982 2,907
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 812,215 0.21 811,715 1,333
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 703,799 0.18 703,799 2
Individuals holding nominal share capital up to Rs. 1 lakh 24,658,808 6.45 24,326,737 83,384
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 9,445 0.00 9,445 8
Others 348,656 0.09 348,656 2
Sub Total 58,074,154 15.18 57,737,583 88,432
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 382,567,140 100.00 382,194,569 88,658

Company Background

Cohance Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cohance Lifesciences Ltd
  • BSE Code : 74679.0
  • ISIN : INE03QK01018

  • Incorporation Year

    2018

  • Registered Office

    8-2-334 SDE Serene Chambers
    3 Floor Avenue 7 Road No 5, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23549414/1142/3311

  • FAX

    91-40-23541152

  • Chairman

    VIVEK SHARMA

  • Managing Director

    Venkatanaga Kali Vara Prasad Raju Vetukuri

  • Company Secretary

    Kundan Kumar Jha

  • Auditor

    Karvy & Co/Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Cohance Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cohance Life 1,020.40 1,080.09 1,024.99 95.63 18.82
Abbott India 31,282.70 6,097.18 5,848.91 47.00 44.71
Astrazeneca Phar 9,487.50 1,330.33 1,295.53 204.91 33.26
P & G Health Ltd 5,605.70 1,166.89 1,151.26 37.05 39.76
Glaxosmi. Pharma 3,427.35 3,530.73 3,407.25 63.18 44.44
Cipla 1,472.20 17,645.00 16,574.34 23.05 20.10
Amrutanjan Healt 740.45 437.58 421.23 42.12 20.84
Guj. Themis Bio. 332.55 174.19 169.82 74.23 44.82
Fermenta Biotec. 318.30 315.24 307.09 13.86 4.10
Bliss GVS Pharma 133.25 638.96 605.46 20.34 11.19
Ambalal Sarabhai 36.95 11.70 3.81 34.21 1.92